alpha-Ergocryptine

0 marketed

This page covers all alpha-Ergocryptine drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting 5-hydroxytryptamine receptor 6, Cytochrome P450 2C9, 5-hydroxytryptamine receptor 1A.

Targets

5-hydroxytryptamine receptor 6, Cytochrome P450 2C9, 5-hydroxytryptamine receptor 1A

Patent intelligence